322 related articles for article (PubMed ID: 19724024)
1. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
2. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Feb; 55(2):176-83. PubMed ID: 19935077
[TBL] [Abstract][Full Text] [Related]
3. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
[TBL] [Abstract][Full Text] [Related]
4. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
Kang BY; Wang W; Palade P; Sharma SG; Mehta JL
J Cardiovasc Pharmacol; 2009 Oct; 54(4):327-34. PubMed ID: 19687748
[TBL] [Abstract][Full Text] [Related]
5. Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice.
Kang BY; Hu C; Ryu S; Khan JA; Biancolella M; Prayaga S; Seung KB; Novelli G; Mehta P; Mehta JL
Physiol Genomics; 2010 Jun; 42(1):42-54. PubMed ID: 20332185
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
[TBL] [Abstract][Full Text] [Related]
7. LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.
Kang BY; Hu C; Prayaga S; Khaidakov M; Sawamura T; Seung KB; Mehta JL
Biochem Biophys Res Commun; 2009 Feb; 379(2):395-9. PubMed ID: 19126408
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
Choi EY; Chang W; Lim S; Song BW; Cha MJ; Kim HJ; Choi E; Jang Y; Chung N; Hwang KC
Eur J Pharmacol; 2010 Feb; 627(1-3):56-62. PubMed ID: 19883640
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
11. Aspirin suppresses cardiac fibroblast proliferation and collagen formation through downregulation of angiotensin type 1 receptor transcription.
Wang X; Lu J; Khaidakov M; Mitra S; Ding Z; Raina S; Goyal T; Mehta JL
Toxicol Appl Pharmacol; 2012 Mar; 259(3):346-54. PubMed ID: 22306536
[TBL] [Abstract][Full Text] [Related]
12. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.
Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL
J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation.
Mehta JL; Hu B; Chen J; Li D
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2203-8. PubMed ID: 12958047
[TBL] [Abstract][Full Text] [Related]
14. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.
Tanaka Y; Tamura K; Koide Y; Sakai M; Tsurumi Y; Noda Y; Umemura M; Ishigami T; Uchino K; Kimura K; Horiuchi M; Umemura S
FEBS Lett; 2005 Mar; 579(7):1579-86. PubMed ID: 15757644
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
[TBL] [Abstract][Full Text] [Related]
16. Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro.
Xu J; Lü XW; Huang Y; Zhu PL; Li J
J Pharm Pharmacol; 2009 Apr; 61(4):503-10. PubMed ID: 19298698
[TBL] [Abstract][Full Text] [Related]
17. Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
Mitra S; Wang X; Khaidakov M; Ding Z; Ayyadevera S; Hearnsberger E; Goyal T; Mehta JL
J Cardiovasc Pharmacol; 2012 Aug; 60(2):187-92. PubMed ID: 22561363
[TBL] [Abstract][Full Text] [Related]
18. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.
Chen J; Li D; Schaefer R; Mehta JL
Atherosclerosis; 2006 Feb; 184(2):295-301. PubMed ID: 16005008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
